Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

See expanded profiles of nearly 1,800 schools. Unlock entering class stats including MCAT, GMAT and GRE scores.

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

"Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver ...

Dr. Jessica Lichter, Assistant Professor and academic hospitalist at Elmhurst Hospital, part of the New York City Health + ...

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...

announced today that it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai (“Icahn School of Medicine”) in New York, NY, to explore the ...

New York City’s Mount Sinai is going big on artificial intelligence ... area has tapped Dr. Girish Nadkarni to chair the Icahn School of Medicine’s artificial intelligence and human health ...

Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that ...